Drug recall
Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit…
FDA recall event 81316 · Class II · RXQ Compounding LLC
Key facts
| Event ID | 81316 |
|---|---|
| Recall numbers | D-0130-2019 |
| Recalling firm | RXQ Compounding LLC |
| Product type | Drugs |
| Products | Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701. NDC 7073197450 |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent. |
| Initiation date | Sep 25, 2018 |
| Report date | Oct 31, 2018 |
| Termination date | Oct 18, 2022 |
| City | Athens |
| State | OH |
| Country | United States |
| FEI number | 3011509553 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: